Share the post "ASTAL LABORATORIES ‘s Latest Q1 Report: Profit Up by 16800% Year-on-Year"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 867.33 % in the past year, substantial increase in net sales/revenue by 7.3 %.
- Profit over the Year and quarter: Significant improvement in profitability for ASTAL LABORATORIES LIMITED. Notable increase of 12892.31 % in net profit Year to Year, ASTAL LABORATORIES LIMITED’s profitability increased by 202.69 % in this quarter.
- EPS over the Year and quarter: EPS increased by 5,633.33 % Year to Year. EPS increased by 54.95 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1.359 Cr | Rs. 12.252 Cr | Rs. 13.146 Cr | + 7.3 % | + 867.33 % |
| Expenses | Rs. 1.36 Cr | Rs. 11.67 Cr | Rs. 10.77 Cr | -7.71 % | + 691.91 % |
| Operating Profit | Rs. -0 Cr | Rs. 0.58 Cr | Rs. 2.38 Cr | + 310.34 % | 0 % |
| OPM % | -0 % | 4.73 % | 18.1 % | + 13.37 % | + 18.1 % |
| Other Income | Rs. 0.012 Cr | Rs. 0 Cr | Rs. 0.034 Cr | 0 % | + 183.33 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0.06 Cr | 0 % | 0 % |
| Depreciation | Rs. 0 Cr | Rs. 0.02 Cr | Rs. 0.01 Cr | -50 % | 0 % |
| Profit before tax | Rs. 0.01 Cr | Rs. 0.56 Cr | Rs. 2.34 Cr | + 317.86 % | + 23300 % |
| Tax % | 0 % | 0 % | 27.76 % | + 27.76 % | + 27.76 % |
| Net Profit | Rs. 0.01 Cr | Rs. 0.56 Cr | Rs. 1.69 Cr | + 201.79 % | + 16800 % |
| EPS in Rs | Rs. 0.03 | Rs. 1.11 | Rs. 1.72 | + 54.95 % | + 5633.33 % |
Today, we’re looking at ASTAL LABORATORIES LIMITED’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 867.33 %. However, it did see a marginal increase of 7.3 % from the previous quarter. Expenses decreased slightly by -7.71 % quarter-on-quarter, aligning with the annual rise of 691.91 %. faced a quarter-on-quarter increase of 310.34 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 18.1 %, but an expansion of 13.37 % sequentially. despite an annual growth of 183.33 %. Depreciation costs fell by -50 % quarter-on-quarter, Profit before tax grew annually by 23300 % but saw an increase from the preceding quarter by 317.86 %.
Tax expenses as a percentage of profits increased slightly by 27.76 % compared to last year, with a more notable quarter-on-quarter increase of 27.76 %. Net profit rose by 16800 % year-on-year but experienced a 201.79 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 5633.33 % but a quarterly rise of 54.95 %. In summary, ASTAL LABORATORIES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1.359 Cr | Rs. 12.252 Cr | Rs. 13.146 Cr | + 7.3 % | + 867.33 % |
| Expenses | Rs. 1.36 Cr | Rs. 11.67 Cr | Rs. 10.77 Cr | -7.71 % | + 691.91 % |
| Operating Profit | Rs. -0 Cr | Rs. 0.58 Cr | Rs. 2.38 Cr | + 310.34 % | 0 % |
| Net Profit | Rs. 0.01 Cr | Rs. 0.56 Cr | Rs. 1.69 Cr | + 201.79 % | + 16800 % |
| EPS in Rs | Rs. 0.03 | Rs. 1.11 | Rs. 1.72 | + 54.95 % | + 5633.33 % |
In reviewing ASTAL LABORATORIES LIMITED’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 867.33 % year-on-year growth, however, there was a minor increase of 7.3 % from the previous quarter. Expenses rose by 691.91 % compared to the previous year, with a decrease of -7.71 % quarter-on-quarter. and saw a 310.34 % increase from the last quarter.
Net Profit showed yearly increase of 16800 %, and experienced a 201.79 % increase from the previous quarter. Earnings Per Share (EPS) rose by 5633.33 % annually, however rose by 54.95 % compared to the last quarter. In essence, while ASTAL LABORATORIES LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
